Therapeutic approaches to diabetic cardiomyopathy: Targeting the antioxidant pathway

Keyphrases

• Therapeutic Approaches 100%
• Cardiovascular Disease 100%
• Heme oxygenase-1 (HO-1) 100%
• Coactivator 100%
• Antioxidant Pathway 100%
• Diabetic Cardiomyopathy 100%
• Proliferator-activated Receptor-γ 66%
• Oxidative Stress 33%
• Pathophysiology 33%
• Molecular Events 33%
• Obesity 33%
• Diabetes 33%
• Diabetic 33%
• Downstream Targets 33%
• Peroxisome Proliferator-activated Receptor 33%
• ROS Production 33%
• Potential Drugs 33%
• Lifestyle Modification 33%
• Myocardial Injury 33%
• Diabetic Heart Disease 33%
• Myocardial Dysfunction 33%
• Heart Disease 33%
• Inflammatory Response 33%
• Myocardial Remodeling 33%
• Production Increase 33%
• Dietary Modification 33%
• Leading Causes of Death 33%
• Targeted Therapy 33%
• Global Epidemic 33%
• Patient-specific Therapy 33%
• Diabetes Disease 33%
• Disease-associated 33%
• Mitochondrial Dysfunction 33%
• Major Locus 33%
• Cytochrome P450 Epoxygenase 33%
• 20-hydroxyeicosatetraenoic Acid (20-HETE) 33%
• Microcirculation Disorders 33%
• Epoxyeicosatrienoic Acids 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Antioxidant 100%
• Diabetic Cardiomyopathy 100%
• Heme Oxygenase 1 100%
• Cardiovascular Disease 100%
• Receptor 66%
• Inflammation 33%
• Diabetes Mellitus 33%
• Pathophysiology 33%
• Heart Disease 33%
• Heart Muscle Injury 33%
• Cytochrome P450 33%
• Epoxyicosatrienoic Acid 33%
• Peroxisome Proliferator Activated Receptor Gamma 33%
• 20 Hydroxyicosatetraenoic Acid 33%